Table 3 Enrichment of HGSOC risk variants in regulatory regions of HOXD9 target genes.

From: Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer

Cell type

 

Ovarian HOXD9 target genes* (n =128)

Fallopian HOXD9 target genes* (n =34)

Gene ±extended boundaries

 

10 kb

25 kb

50 kb

100 kb

10 kb

25 kb

50 kb

100 kb

K–S test

 

4.2 × 10−4

0.004

0.006

3.9 × 10−6

0.001

3.7 × 10−6

2.4 × 10−7

5 × 10−6

Fisher’s exact test threshold

P<10−3

4.9 × 10−10

7.9 × 10−14

1.9 × 10−18

5.2 × 10−14

1.1 × 10−15

3 × 10−11

4.4 × 10−13

3.4 × 10−9

 

P<10−4

6 × 10−10

8.5 × 10−14

1.2 × 10−20

1.2 × 10−31

5 × 10−20

8.5 × 10−17

1.1 × 10−21

3.8 × 10−16

 

P<10−5

No SNPs

No SNPs

No SNPs

No SNPs

0.876

0.779

0.178

0.005

  1. *FDR<0.1 for differential expression and fold change >±2 after HOXD9 overexpression.